Global Generic Drugs Market Growth (Status and Outlook) 2025-2031
Description
According to this study, the global Generic Drugs market size will reach US$ 397400 million by 2031.
A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, route of administration, quality, performance, and intended use. The term may also refer to any drug marketed under its chemical name without advertising, or to the chemical makeup of a drug rather than the brand name under which the drug is sold.
The generic drugs market is driven by the rising demand for cost-effective medications, especially as healthcare systems worldwide face increasing financial pressures. The expiration of patents on numerous blockbuster drugs opens opportunities for generic manufacturers to enter the market with more affordable alternatives. Additionally, supportive government policies, regulatory incentives, and growing acceptance of generics by healthcare providers and patients contribute to the market’s rapid expansion.
A key challenge in the generic drugs market is the intense price competition, which can squeeze profit margins and discourage innovation. Regulatory hurdles and delays in approval processes can also limit timely market entry. Furthermore, concerns about the quality and consistency of some generics—particularly in developing markets—may affect consumer trust and hinder adoption despite cost advantages.
LPI (LP Information)' newest research report, the “Generic Drugs Industry Forecast” looks at past sales and reviews total world Generic Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Generic Drugs sales for 2025 through 2031. With Generic Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Generic Drugs industry.
This Insight Report provides a comprehensive analysis of the global Generic Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Generic Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Generic Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Generic Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Generic Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Generic Drugs market by product type, application, key players and key regions and countries.
Segmentation by Type:
Prescription
Non-Prescription Drugs
Segmentation by Application:
CNS
Cardiovascular
Genitourinary/Hormonal Drugs
Respiratory
Rheumatology
Diabetes
Oncology
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Teva
Sandoz
Viatris
Sun Pharmaceutical
Aspen
Fresenius Kabi
Pfizer (Hospira)
Sanofi
Aurobindo
Lupin
Dr. Reddy's
Apotex
Cipla
ENDO (Par Pharmaceutical)
Stada Arzneimittel
Krka Group
Nichi-Iko Pharmaceutical
Valeant
Zydus Cadila
Hikma
Pharmaniaga Berhad
Hovid Berhad
Duopharma Biotech
Kotra Pharma
HOE Pharmaceutical
Y.S.P. Industries
Please note: The report will take approximately 2 business days to prepare and deliver.
A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, route of administration, quality, performance, and intended use. The term may also refer to any drug marketed under its chemical name without advertising, or to the chemical makeup of a drug rather than the brand name under which the drug is sold.
The generic drugs market is driven by the rising demand for cost-effective medications, especially as healthcare systems worldwide face increasing financial pressures. The expiration of patents on numerous blockbuster drugs opens opportunities for generic manufacturers to enter the market with more affordable alternatives. Additionally, supportive government policies, regulatory incentives, and growing acceptance of generics by healthcare providers and patients contribute to the market’s rapid expansion.
A key challenge in the generic drugs market is the intense price competition, which can squeeze profit margins and discourage innovation. Regulatory hurdles and delays in approval processes can also limit timely market entry. Furthermore, concerns about the quality and consistency of some generics—particularly in developing markets—may affect consumer trust and hinder adoption despite cost advantages.
LPI (LP Information)' newest research report, the “Generic Drugs Industry Forecast” looks at past sales and reviews total world Generic Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Generic Drugs sales for 2025 through 2031. With Generic Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Generic Drugs industry.
This Insight Report provides a comprehensive analysis of the global Generic Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Generic Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Generic Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Generic Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Generic Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Generic Drugs market by product type, application, key players and key regions and countries.
Segmentation by Type:
Prescription
Non-Prescription Drugs
Segmentation by Application:
CNS
Cardiovascular
Genitourinary/Hormonal Drugs
Respiratory
Rheumatology
Diabetes
Oncology
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Teva
Sandoz
Viatris
Sun Pharmaceutical
Aspen
Fresenius Kabi
Pfizer (Hospira)
Sanofi
Aurobindo
Lupin
Dr. Reddy's
Apotex
Cipla
ENDO (Par Pharmaceutical)
Stada Arzneimittel
Krka Group
Nichi-Iko Pharmaceutical
Valeant
Zydus Cadila
Hikma
Pharmaniaga Berhad
Hovid Berhad
Duopharma Biotech
Kotra Pharma
HOE Pharmaceutical
Y.S.P. Industries
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
169 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Generic Drugs Market Size by Player
- 4 Generic Drugs by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global Generic Drugs Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
